Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DB25FJD30
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,185
Award facts
- Contract value 100% obligated
- $26,184.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $26,184.60 to AmerisourceBergen Drug Corp for the supply of Cosentyx (secukinumab) 300mg dose in 2 pen/mL formulation. This is a firm fixed-price delivery order with no set-aside designation, issued on July 29, 2025, with an ultimate completion date of July 30, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement through the DLA's Medical Supply Chain. The parent company holds a comprehensive global pharmaceutical support vehicle enabling it to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Cosentyx is a specialty immunosuppressive medication used in the treatment of autoimmune conditions, reflecting the company's portfolio of specialized medical commodities that support Defense Health Agency and other government healthcare systems. This competitively awarded contract demonstrates AmerisourceBergen's established capability to fulfill federal pharmaceutical procurement requirements efficiently within the military medical supply infrastructure.
Quick answers
Who was awarded contract SPE2DB25FJD30?
SPE2DB25FJD30 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 29, 2025.
How much is contract SPE2DB25FJD30 worth?
The government has obligated $26,185 on SPE2DB25FJD30.
Is contract SPE2DB25FJD30 an order under another contract?
Yes. SPE2DB25FJD30 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJD30 competed?
The extent of competition for SPE2DB25FJD30 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award